NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · IEX Real-Time Price · USD
1.140
-0.040 (-3.39%)
Apr 18, 2024, 4:00 PM EDT - Market closed

NMTC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year 202320222021202020192017
Revenue
3.412.120.241.9300
Revenue Growth (YoY)
60.73%772.60%-87.39%---
Cost of Revenue
1.50.240.28000
Gross Profit
1.911.88-0.031.9300
Selling, General & Admin
6.936.986.264.754.282.34
Research & Development
6.944.933.932.081.530.74
Operating Expenses
13.8711.9110.196.835.813.07
Operating Income
-11.96-10.03-10.22-4.9-5.81-3.07
Interest Expense / Income
0007.520.281.4
Other Expense / Income
-0.1-0.03-0.271.210.680.59
Pretax Income
-11.86-10-9.95-13.64-6.78-5.06
Net Income
-11.86-10-9.95-13.64-6.78-5.06
Shares Outstanding (Basic)
181611542
Shares Outstanding (Diluted)
181611542
Shares Change
13.27%49.56%97.52%37.01%79.39%-
EPS (Basic)
-0.65-0.63-0.93-2.52-1.71-2.31
EPS (Diluted)
-0.65-0.63-0.93-2.52-1.71-2.31
Free Cash Flow
-13.26-7.79-8.67-3.55-5.45-2.11
Free Cash Flow Per Share
-0.73-0.49-0.81-0.66-1.38-0.96
Gross Margin
56.10%88.59%-13.56%100.00%--
Operating Margin
-350.84%-473.14%-4205.75%-254.46%--
Profit Margin
-348.03%-471.67%-4094.60%-708.00%--
Free Cash Flow Margin
-389.23%-367.67%-3568.48%-184.15%--
EBITDA
-11.55-9.77-9.8-6.05-6.47-3.65
EBITDA Margin
-338.96%-461.00%-4032.79%-313.77%--
Depreciation & Amortization
0.310.230.150.070.030.02
EBIT
-11.86-10-9.95-6.12-6.5-3.66
EBIT Margin
-348.03%-471.67%-4093.35%-317.43%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).